Latest News
Omnes Capital has acquired a stake in Ducatillon as part of a buyer-in-management-buy-out (BIMBO) deal worth a total of EUR7.6 million.
Omnes Capital’s small cap fund, with the support of Bpifrance, is accompanying the handover of the company’s management and shareholding from chairman Thomas Delecroix to buyer Jean-Marc Bernard.
Founded in 1997, Ducatillon is France’s market leader in distance selling of hobby farming and hunting equipment and outdoor leisure goods. The company, which offers over 22,000 items, has a multi-specialist positioning in France spanning hunting attire and accessories, livestock equipment, gardening products, kitchen goods, canine accessories and fishing equipment.
CVC Credit Partners and the EQT Mid-Market Credit Fund’s European Private Debt businesses have jointly provided a GBP110 million unitranche facility to Paymentsense.
As Europe’s largest merchant services provider, Paymentsense specialises in providing fast, affordable and reliable card processing services to over 50,000 small and medium-sized businesses processing GBP5bn of transactions per annum.
Chris Fowler, managing director in CVC Credit Partners’ direct lending business, says: “UK businesses are constantly looking for alternative ways to financially support their growth plans, and now so more than ever. Paymentsense is a very exciting company, with a differentiated business model, an entrepreneurial management
YFM Equity Partners has sold its investment in GO Outdoors, the outdoor clothing and equipment retailer, to JD Sports Fashion in a GBP130 million deal.
The sale, together with the partial realisation in 2011, means that YFM has achieved close to 40x its original investment, with a GBP23 million total return.
When YFM originally invested alongside the founders Paul Caplan and John Graham, there was just one store in Sheffield generating GBP2 million in sales.
YFM helped GO Outdoors to professionalise the board and to manage its growth supporting the introduction of the membership store discount card and
Pan-European private equity firm IK Investment Partners has raised aggregate commitments totalling EUR1.85 billion for its eighth mid cap fund, the IK VIII Fund.
Fundraising commenced in March 2016, and has seen strong demand from both existing and new investors.
The fund exceeded its EUR1.6 billion target and secured commitments of EUR1.85 billion from an institutional investor base with a geographical spread across North America (37 per cent), Europe (52 per cent), Middle East (5 per cent) and Asia (2 per cent).
The fund will continue to execute the same strategy applied to previous IK funds, making majority
John Paul, a specialist in the concierge market, has joined AccorHotels in a transaction led by Cambon Partners.
John Paul was established in Paris in 2007 and merged with American company LesConcierges in 201.
John Paul has over 1,000 employees around the world who are available 24/7 to cater to their customers’ every request, from the simplest to the most extravagant, anywhere around the globe.
AccorHotels will leverage John Paul’s expertise to take the group’s strategy – placing customer satisfaction at the centre of its activity – to the next level, and to generate new revenue streams from
Gide has advised Rivadis Group, which specialises in cosmetics, on the sale to L'Oréal of the Société Thermes de Saint-Gervais-les-Bains, which operates the Saint-Gervais-les-Bains spa establishment as part of a public service delegation contract, and of its cosmetics and skincare production and commercialisation business, under the brand name Saint-Gervais Mont-Blanc.
For 20 years, the Rivadis Group has created and developed a range of cosmetics integrating thermal spring water.
This transaction is part of a corporate strategy to reposition the group and to concentrate its resources on the development of its own brands, Rivadouce, Auriège and Milton.
Gide’s team
Noerr is advising ISS Facility Holding Services, subsidiary of the listed Danish company ISS, on its acquisition of EVANTEC from Luxemburg private equity fund palero invest.
ISS was the successful bidder in a structured auction process.
ISS is relying on a Noerr team led by the Berlin corporate partner Christoph Spiering.
The ISS Group, a facility services provider with sales of EUR10.66 billion, is taking over a company specialising in facility management services in the German energy industry. With a workforce of some 800, the former E.ON subsidiary EVANTEC offers its customers, which include key power plant operators,
Independent investment bank Zeus Capital has appointed Rachel Birkett as research analyst in its Manchester office.
Birkett, who is a qualified chartered accountant, joins from Brown Shipley where she spent two years as a company analyst and fund manager. In this role, Birkett researched the consumer discretionary sector of the FTSE350 to identify trends and support investment cases, as well as managing a concentrated portfolio of GBP90 million fixed income investments.
Birkett also worked for three years as an audit assistant manager at business advisory firm Deloitte, covering field managing statutory audits across a range of industry sectors. Having
A consortium comprising the Russian Direct Investment Fund (RDIF), Singapore’s Changi Airports International (CAI) and Russia’s Basic Element is to acquire Vladivostok International Airport in Russia’s Far East from Sheremetyevo International Airport.
Upon regulatory and corporate approvals, the consortium will own 100 per cent of JSC Terminal Vladivostok which owns and operates the airport terminal building, and 52.16 per cent of JSC International Airport Vladivostok which holds the airport license.
RDIF, CAI and Basic Element each hold an equal interest of 33.3 per cent.
Kirill Dmitriev, CEO of the RDIF, says: “We have been working diligently and have
ORI Healthcare Fund has led a USD100 million series C investment in Kymab Group, a UK Cambridge-based company focusing on generating antibodies to treat challenging diseases based on the proprietary Kymouse antibody platform.
ORI Fund is the lead investor in the series; other investors include Wellcome Trust, Bill & Melinda Gates Foundation, Shenzhen Hepalink Pharmaceutical, Malin Corporation, CF Woodford Equity Income Fund and Woodford Patient Capital.
Kymab's Kymouse platform contains the entire repertoire of human antibodies. The platform has the capability to discover antibodies that are difficult to develop and produce as it naturally matures these molecules to highly
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
